The Serendipitous Origins of Moderna’s COVID-19 Vaccine..

First published at 07:57 UTC on March 22nd, 2022.
subscribers

Since January 2020, the value of Moderna’s stock—which had embarked on a steady decline since its IPO—grew from $18.89 per share to its current value of $339.57 per share, thanks to the success of its COVID-19 vaccine.

When the genetic sequence of…

MORE
CategoryNews & Politics
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO